An algorithm might help to arrange a timely advance care planning conversation to agree with patients on their goals and wishes. The timing of such a discussion is crucial, and data have shown that the [more]
While we’re pouring resources into learning what keeps cancer cells alive, with the aim of blocking their supply lines, there is next to no interest in the molecular pathways that end up choking the life [more]
Among patients hospitalised for advanced lung cancer, the prescription of preventative medicines for diabetes, hypertension, hyperlipidemia, antiplatelet agents, and vitamins/minerals is very common not only at the moment of admission, but also at discharge, according [more]
Efforts to improve symptom control near the end of life have received more attention in recent years, but the impact is often frustratingly small. Simon Crompton asks where we are going wrong. Seven years ago, [more]
The Journal of Medical Ethics recently published the results of an Australian survey involving 96 physicians from 10 medical specialties who were asked why patients at the end of life are often prescribed treatments that [more]
This hard-hitting blogpost by Ken Murray, a retired Los Angeles family doctor, helped open up discussions about why doctors routinely administer treatments to dying patients that they would adamantly refuse for themselves. Years ago, Charlie, [more]
People with cancer have time to think. Not every patient will think about spiritual matters, but most of us probably do, either alone, or when talking with close family or friends. People with cancer have [more]
Why are cancer patients being given medically futile treatment in the last weeks of their life? We hear this question raised time and again at international meetings and in journal articles, provoking polarised views and [more]